Abstract:NALFD is becoming a global epidemic with severe complications, but few if any pharmacological therapies are available. Owing to its unique anatomy, microarchitecture, and cellular composition, the liver functions as an immune organ in addition to its roles in metabolism and detoxification. Innate immune signaling controls both inflammatory and metabolic profiles in the liver, and has potential to provide novel therapeutic targets in non-alcoholic steatohepatitis (NASH). Innate immune components mediate both canonical inflammation cascades and noncanonical metabolism-related pathways by modulating post-translational modifications or transcriptional coregulation, thus controlling NASH progression. Multi-omic analyses, cell signaling, and tissue-specific gene-editing technologies, combined with advances in disease models, will facilitate in-depth understanding of NAFLD and the discovery of new drugs. Non-alcoholic fatty liver disease (NAFLD) has become the most epidemic liver disease worldwide owing to rapid changes in lifestyle over the past few decades. This chronic condition intertwines with low-grade inflammation and metabolic disequilibrium, and potentiates the onset and progression of devastating hepatic and extrahepatic complications. In addition to an integral role in promoting host defense, recent studies also implicate innate immune signaling in a multitude of processes that control the progression of NAFLD. The focus of this review is to highlight emerging evidence regarding the role of innate immunity in NAFLD and the integration of different pathways that affect both inflammation and metabolism across the spectrum of this liver morbidity. Non-alcoholic fatty liver disease (NAFLD) has become the most epidemic liver disease worldwide owing to rapid changes in lifestyle over the past few decades. This chronic condition intertwines with low-grade inflammation and metabolic disequilibrium, and potentiates the onset and progression of devastating hepatic and extrahepatic complications. In addition to an integral role in promoting host defense, recent studies also implicate innate immune signaling in a multitude of processes that control the progression of NAFLD. The focus of this review is to highlight emerging evidence regarding the role of innate immunity in NAFLD and the integration of different pathways that affect both inflammation and metabolism across the spectrum of this liver morbidity.

Innate Immune Signaling in Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases.

Role of Innate Immune Signaling in Non-Alcoholic Fatty Liver Disease

Innate Immune Signaling and Its Role in Metabolic and Cardiovascular Diseases.

Role of Innate Immune Response in Non-Alcoholic Fatty Liver Disease: Metabolic Complications and Therapeutic Tools

The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis

Innate immunity and nonalcoholic fatty liver disease

Reprogramming Innate Immune Signaling in Cardiometabolic Disease

Innate Immune Regulatory Networks in Hepatic Lipid Metabolism

The regulatory role of metabolic organ-secreted factors in the nonalcoholic fatty liver disease and cardiovascular disease.

The Role of Innate Immune Cells in Nonalcoholic Fatty Liver Disease

Innate Immune System in the Pathogenesis of Non-Alcoholic Fatty Liver Disease

The innate immune signaling in cancer and cardiometabolic diseases: Friends or foes?

Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases

Emerging Molecular Targets for Treatment of Nonalcoholic Fatty Liver Disease

Innate Immune Response in Non Alcoholic Fatty Liver Disease: An Overview of Alterations in TLR9, Macrophages, and TNFα

Molecular mechanisms of metabolic disease-associated hepatic inflammation in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

The contribution of the gut-liver axis to the immune signaling pathway of NAFLD

Endothelial‐immune crosstalk contributes to vasculopathy in nonalcoholic fatty liver disease

The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases

Liver-derived metabolites as signaling molecules in fatty liver disease

New Paradigms in Inflammatory Signaling in Vascular Endothelial Cells